Covid-19: Xenothera, a Nantes Start-Up, will Test an Antibody-Based Treatment
Patients from the Nantes University Hospital, suffering from a moderate form of Covid-19, could benefit from a clinical trial from Xenothera in June 2020. It’s a time trial race. While the epidemic of the new coronavirus has already claimed at least 141,000 deaths worldwide, including 17,920 in France according to the latest official report, researchers are mobilizing to find an effective treatment against the disease. “It is […]
Continue Reading